Kim Chang Hwan, Kim Dong Jin, Kim Wook
Department of Surgery, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ann Surg Treat Res. 2021 Sep;101(3):151-159. doi: 10.4174/astr.2021.101.3.151. Epub 2021 Aug 31.
Perforated gastric cancer is an extremely rare condition and usually presents in advanced stage with poor prognosis. Surgical strategies are still controversial regarding the extent to which complete resection or primary repair is performed and the application of laparoscopic techniques. We aim to determine the role of laparoscopic 2-stage approach in perforated gastric cancer.
Among 2,318 gastric cancers in Yeouido St. Mary's Hospital from January 1990 to December 2017, 20 patients with perforated gastric cancer were enrolled, and 5 patients underwent 2-stage gastrectomy consisting of primary closure on perforation followed by curative gastrectomy. Clinicopathological features, surgical outcomes, and survival analysis were evaluated.
Two-stage approach for perforated gastric cancer was all performed by laparoscopic approach except 1 patient who needed paraaortic lymph node dissection (LND). Those were first treated on peritonitis with laparoscopic primary closure with or without Foley gastrostomy. Compared to 1-stage gastrectomy, more D2 LND was performed (60.0% . 100.0%, P = 0.260) and retrieved lymph nodes were significantly higher (median [range]: 17.0 [12.0-27.0] . 33.0 [26.5-43.5], P = 0.019]. Two patients of stage II and 3 patients of stage III were included in the 2-stage gastrectomy group. During the 38 months of median follow-up period, there were 8 and 1 recurrence among 1-stage and 2-stage gastrectomies, respectively. Except for 1 patient, 4 other 2-stage patients survived around 5 years without recurrence (5-year disease-free survival, 80%).
Laparoscopic 2-stage surgery for perforated gastric cancer is safe and might increase the curability of gastrectomy with extended LND.
胃穿孔性癌极为罕见,通常在晚期出现,预后较差。关于进行完全切除或一期修复的程度以及腹腔镜技术的应用,手术策略仍存在争议。我们旨在确定腹腔镜两阶段手术方法在胃穿孔性癌中的作用。
在1990年1月至2017年12月于首尔圣母医院的2318例胃癌患者中,纳入20例胃穿孔性癌患者,其中5例接受了两阶段胃切除术,包括穿孔处的一期缝合,随后进行根治性胃切除术。评估了临床病理特征、手术结果和生存分析。
除1例需要主动脉旁淋巴结清扫(LND)的患者外,胃穿孔性癌的两阶段手术均通过腹腔镜手术进行。这些患者首先接受腹腔镜一期缝合(有或无Foley胃造口术)治疗腹膜炎。与一期胃切除术相比,进行D2 LND的比例更高(60.0%对100.0%,P = 0.260),回收的淋巴结明显更多(中位数[范围]:17.0[12.0 - 27.0]对33.0[26.5 - 43.5],P = 0.019)。两阶段胃切除组包括2例II期患者和3例III期患者。在中位随访期38个月期间,一期和两阶段胃切除术中分别有8例和1例复发。除1例患者外,其他4例两阶段手术患者存活约5年无复发(5年无病生存率,80%)。
腹腔镜两阶段手术治疗胃穿孔性癌是安全的,可能会提高扩大LND的胃切除术的治愈率。